Physician profile
John Cuellar
NPI 1639134422
$14,969.45
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,366 · 2020: $209 · 2021: $1,668 · 2022: $4,531 · 2023: $3,075 · 2024: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,915 · Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,915.01 |
| Food and Beverage | $280.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $7,055.73 | 2022-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $4,725.32 | 2019-2021 | |
| Covidien LP | $715.07 | 2019 | |
| Abbvie INC. | $569.71 | 2019-2023 | Orilissa |
| Coloplast Corp | $352.19 | 2019 | |
| Coopersurgical, INC. | $182.62 | 2019-2020 | |
| Therapeuticsmd, INC. | $171.01 | 2019-2020 | |
| Healthtronics Stone Solutions, LLC | $153.52 | 2019-2021 | |
| Pfizer INC. | $138.15 | 2019-2023 | |
| Novo Nordisk INC | $125.00 | 2021 | |
| Stryker Corporation | $120.12 | 2024 | Variax, Gamma |
| Intuitive Surgical, INC. | $116.99 | 2019 | |
| Astellas Pharma US INC | $94.38 | 2019-2022 | |
| Myriad Women'S Health, INC. | $91.57 | 2023 | Myrisk |
| Smith+Nephew, INC. | $51.94 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $51.91 | 2022 | |
| Minerva Surgical, INC | $50.40 | 2021 | |
| Conmed Corporation | $41.67 | 2019 | |
| Daiichi Sankyo INC. | $36.00 | 2019-2020 | |
| Axonics, INC. | $25.61 | 2022 | |
| Mayne Pharma Commercial LLC | $25.19 | 2023 | |
| Osiris Therapeutics INC. | $20.71 | 2019 | |
| Dermira, INC. | $18.47 | 2019 | |
| Urovant Sciences INC | $12.71 | 2022 | |
| Boston Scientific Corporation | $11.92 | 2022 | |
| Mission Pharmacal Company | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cuellar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.